DOXYCYCLINE
Doxycycline for Injection, USP To reduce the development of drug–resistant bacteria and maintain the effectiveness of Doxycycline for Injection, USP and other antibacterial drugs, Doxycycline for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
Approved
Approval ID
fa3fbb09-b830-60c5-e053-6394a90a4165
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 26, 2023
Manufacturers
FDA
FOSUN PHARMA USA INC
DUNS: 080920998
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
DOXYCYCLINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72266-237
Application NumberANDA215583
Product Classification
M
Marketing Category
C73584
G
Generic Name
DOXYCYCLINE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 26, 2023
FDA Product Classification
INGREDIENTS (3)
ASCORBIC ACIDInactive
Quantity: 480 mg in 10 mL
Code: PQ6CK8PD0R
Classification: IACT
MANNITOLInactive
Quantity: 300 mg in 10 mL
Code: 3OWL53L36A
Classification: IACT
DOXYCYCLINE HYCLATEActive
Quantity: 100 mg in 10 mL
Code: 19XTS3T51U
Classification: ACTIM